Testing effectiveness (Phase 2)Study completedNCT00036660
What this trial is testing
SarCNU in Treating Patients With Recurrent Malignant Glioma
Who this might be right for
Brain and Central Nervous System Tumors
NCIC Clinical Trials Group 10
Showing 20 of 0 results